
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Indian Kino Bark from Pterocarpus marsupium contains kino tannic acid and pterostilbene that inhibit aldose reductase and regulate glucose metabolism through pancreatic beta-cell regeneration. The bark's flavonoids including marsupin and liquiritigenin provide anti-inflammatory effects by inhibiting COX-1/2 and reducing PGE2 production.

Reported Benefits (Provisional)
Origin & History

Indian Kino Bark (Pterocarpus marsupium) is native to the dry deciduous forests and rocky hillsides of India, Sri Lanka, and parts of Nepal. This Ayurvedic botanical is highly valued for its potent properties in supporting blood sugar regulation and liver detoxification.
Research Narrative (Provisional)
Extensive research, including clinical trials, supports Indian Kino Bark's significant role in blood sugar regulation and its potent antioxidant and anti-inflammatory effects. Studies highlight its active compounds like pterostilbene for metabolic and hepatoprotective benefits, validating its traditional Ayurvedic applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals: Pterostilbene, marsupsin, epicatechin, quercetin, tannic acid, lignans, flavonoids. - Minerals: Iron, manganese, chromium. - Bioactive Properties: Antidiabetic, antioxidant, anti-inflammatory.
Reported Mechanism (Provisional)
The bark's primary compounds including pterostilbene, marsupin, and kino tannic acid inhibit aldose reductase enzyme, preventing diabetic complications through the polyol pathway. These bioactives also regenerate pancreatic beta-cells and islets of Langerhans while modulating glucose metabolism. Anti-inflammatory mechanisms involve COX-1/2 inhibition and reduced prostaglandin E2 (PGE2) synthesis in LPS-stimulated cells.
Clinical Narrative (Provisional)
Current evidence relies primarily on preclinical animal studies rather than human clinical trials with quantified outcomes. In streptozotocin-induced diabetic rats, 60-day bark extract treatment prevented cataracts by preserving lens proteins and glutathione levels. Rat studies demonstrate anti-inflammatory effects in carrageenan-induced paw edema models, but specific dosages and percentage improvements lack documentation. Human randomized controlled trials with measured endpoints like HbA1c reduction or glucose control are notably absent from current literature.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







